RADIENT PHARMACEUTICALS Corp 4/A
4/A · RADIENT PHARMACEUTICALS Corp · Filed Oct 19, 2009
Insider Transaction Report
Form 4/AAmended
ARQUILLA EDWARD R
Director
Transactions
- Award
Options
2009-10-14$0.75/sh+20,000$15,000→ 80,000 totalExercise: $0.75From: 2008-03-03Exp: 2013-03-03→ Common Stock (20,000 underlying) - Award
Options
2009-10-14$0.75/sh+20,000$15,000→ 40,000 totalExercise: $0.75From: 2006-10-09Exp: 2011-10-08→ Common Stock (20,000 underlying) - Award
Options
2009-10-14$0.75/sh+20,000$15,000→ 20,000 totalExercise: $0.75From: 2006-02-27Exp: 2011-02-27→ Common Stock (20,000 underlying) - Award
Options
2009-10-14$0.75/sh+20,000$15,000→ 60,000 totalExercise: $0.75From: 2007-06-01Exp: 2012-05-31→ Common Stock (20,000 underlying)
Holdings
- 56,494
Common Stock
Footnotes (4)
- [F1]Repricing of the exercise price of options originally granted February 27, 2006 with an exercise price of $2.85
- [F2]Repricing of the exercise price of the options originally granted October 9, 2006 with an exercise price of $3.70
- [F3]Repricing of the exercise price of the options originally granted June 1, 2007 with an exercise price of $4.06
- [F4]Repricing of the exercise price of the options originally granted March 3, 2008 with an exercise price of $3.45